Tina-Quant Hemoglobin A1C
Assay, Glycosylated Hemoglobin. 510(k) K934070, from Boehringer Mannheim Corp. (Indianapolis, IN). Product code LCP, class 2.
As of Nov 19, 2026, K934070 is an FDA 510(k) held by Boehringer Mannheim Corp., substantially equivalent on Oct 11, 1994 after 417 days, with no recalls tied to it in FDA's recall database.
- Review time: 417 days
- Recalls: 0
- Cited as a predicate by: 6 devices
- Vigil Hemoglobin (Hbalc) ControlsK982022 · Beckman Coulter, Inc. · Jul 6, 1998
- Accu-Chek A1C Hemoglobin TestK974491 · Boehringer Mannheim Corp. · May 13, 1998
- Synchron System Hemoglobin Alc ReagentK973696 · Beckman Instruments, Inc. · Nov 24, 1997
- Tina-Quant Hemoglobin A1C GEN.2 TestK052464 · Roche Diagnostics Corp. · Sep 30, 2005
- C.F.A.S. (Calibrator for Automated Systems) HBA1CK052101 · Roche Diagnostics · Aug 26, 2005
- GlycomarkK031604 · Tomen America, Inc. · Sep 22, 2003
- Q-Pad Test SystemK231465 · Qurasense · Dec 6, 2023
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Aug 20, 1993
- Review panel
- Hematology
- Regulation
- 21 CFR 864.7470
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files